WW · WW International reported Q3 2026 revenue of $152.9M, down 11% YoY, but…

WW International reported Q3 2026 revenue of $152.9M, down 11% YoY, but swung to a net income of $15.1M from a $57.5M loss a year ago. Clinical subscription revenue grew 48% YoY to $38.0M, and the company narrowed its full-year revenue guidance to $625M-$630M and raised its Adjusted EBITDA guidance to $110M-$115M. The positive net income and guidance raise are notable, but the ongoing revenue decline from the shrinking behavioral business tempers the outlook.

• Q3 2026 revenue of $152.9M, down 11% YoY from $172.1M
• Clinical subscription revenue of $38.0M, up 48% YoY, representing 25% of total revenue
• Net income of $15.1M vs net loss of $57.5M in Q3 2025
• Adjusted EBITDA of $51.7M, up 21% YoY from $42.8M, with a 33.8% margin